To serve the ranitidina, review prohibits its commercialization in El Salvador | El Salvador News

The National Medicines Agency has suspended the commercialization and consumption in the country of the pharmacies that contain ranitidina.

El Salvador is on the list of countries that have suspended the use of oral drugs that contain ranitidina through the advertisements of international experts that you can cause cancer.

The ranitidina has been used to treat peptic acidosis: acidosis, gastritis, gastric ulcer, esophageal reflux, among others.

The consumption of this medicine, in addition, can produce adverse reactions, according to the National Library of Medicine of the EU.UU., exposing international media, including the details:

– Training

– Diarrhea

Malestar estomacal

– Vómitos

– Stomach pain

The National Directorate of Medicines (DNM) indicates the decision to withdraw from the salvador market this pharmacy obtains the sanitary warnings issued in compliance with the Food and Drug Administration of the United States (FDA and its Seals in English) Medicamentos (EMA).

These organisms have been detected in drugs based on the presence of an impurity identified as N-Nitrosodimethylamine (NDMA), a substance that can provoke cancer, in agreement with international media publications.

LEA ADEMÁS: Las medicines con ranitidina quedan prohibidas en El Salvador

The Executive Director of the DNM, Francisco Cortez Morales, set out a journey of a memorandum of February 2, 2021 to establish the FDA and the EMA that yield the normal norms of the almacenamiento, and that it has a temperature of will have all kinds of fit from the factory. , increase the levels of NDMA in the ranitidina, by increasing the risk of cancer in persons exposing to higher levels of NDMA at acceptable levels over a long period of time.

The DNM not only informs that withholding from the Sale of Medicines List Free of charge medicines in El Salvador, we are, in addition, realizing vigilance regarding the sale of these; We will also notify healthcare professionals about the new provision, which will provide its patients with other alternative therapies.

“It is not uncommon to see that this drug does not affect drug abstinence, given that there are other drugs on the market, with other active principles, that have the same therapeutic indications as omeprazole, pantoprazole or lansoprazole; and the antagonists of the H2 receptors, like the famotidina ”, signaled the DNM.

TE PUEDE INTERESTS: El Salvador initiates evacuation against COVID-19 first line staff

.Source